IRIS Accounts Production v25.1.3.33 SC483772 director 1.9.23 31.8.24 31.8.24 false true false false true false Ordinary 'A' 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWhSC4837722023-08-31SC4837722024-08-31SC4837722023-09-012024-08-31SC4837722022-08-31SC4837722022-09-012023-08-31SC4837722023-08-31SC483772ns15:Scotland2023-09-012024-08-31SC483772ns14:PoundSterling2023-09-012024-08-31SC483772ns10:Director12023-09-012024-08-31SC483772ns10:PrivateLimitedCompanyLtd2023-09-012024-08-31SC483772ns10:SmallEntities2023-09-012024-08-31SC483772ns10:AuditExempt-NoAccountantsReport2023-09-012024-08-31SC483772ns10:SmallCompaniesRegimeForDirectorsReport2023-09-012024-08-31SC483772ns10:SmallCompaniesRegimeForAccounts2023-09-012024-08-31SC483772ns10:FullAccounts2023-09-012024-08-31SC483772ns10:OrdinaryShareClass12023-09-012024-08-31SC483772ns10:RegisteredOffice2023-09-012024-08-31SC483772ns5:CurrentFinancialInstruments2024-08-31SC483772ns5:CurrentFinancialInstruments2023-08-31SC483772ns5:ShareCapital2024-08-31SC483772ns5:ShareCapital2023-08-31SC483772ns5:RetainedEarningsAccumulatedLosses2024-08-31SC483772ns5:RetainedEarningsAccumulatedLosses2023-08-31SC483772ns5:WithinOneYearns5:CurrentFinancialInstruments2024-08-31SC483772ns5:WithinOneYearns5:CurrentFinancialInstruments2023-08-31SC483772ns10:OrdinaryShareClass12024-08-31SC4837721ns10:Director12023-08-31SC4837721ns10:Director12022-08-31SC4837721ns10:Director12023-09-012024-08-31SC4837721ns10:Director12022-09-012023-08-31SC4837721ns10:Director12024-08-31SC4837721ns10:Director12023-08-31
















Unaudited Financial Statements for the Year Ended 31 August 2024

for

Qualipharm Consultancy Ltd

Qualipharm Consultancy Ltd (Registered number: SC483772)






Contents of the Financial Statements
for the Year Ended 31 August 2024




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 3


Qualipharm Consultancy Ltd

Company Information
for the Year Ended 31 August 2024







DIRECTOR: Ms C Tsang





REGISTERED OFFICE: 2 Melville Street
Falkirk
FK1 1HZ





REGISTERED NUMBER: SC483772 (Scotland)





ACCOUNTANTS: Ian Macfarlane Limited
Chartered Accountants
2 Melville Street
Falkirk
FK1 1HZ

Qualipharm Consultancy Ltd (Registered number: SC483772)

Balance Sheet
31 August 2024

31.8.24 31.8.23
Notes £    £   
CURRENT ASSETS
Debtors 4 8,772 8,676
Cash at bank and in hand 232,609 227,365
241,381 236,041
CREDITORS
Amounts falling due within one year 5 48,128 29,756
NET CURRENT ASSETS 193,253 206,285
TOTAL ASSETS LESS CURRENT
LIABILITIES

193,253

206,285

CAPITAL AND RESERVES
Called up share capital 6 1 1
Retained earnings 193,252 206,284
SHAREHOLDERS' FUNDS 193,253 206,285

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 August 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 August 2024 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges her responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the director and authorised for issue on 27 May 2025 and were signed by:





Ms C Tsang - Director


Qualipharm Consultancy Ltd (Registered number: SC483772)

Notes to the Financial Statements
for the Year Ended 31 August 2024

1. STATUTORY INFORMATION

Qualipharm Consultancy Ltd is a private company, limited by shares , registered in Scotland. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 1 (2023 - 1 ) .

4. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.8.24 31.8.23
£    £   
Trade debtors 8,772 8,676

5. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.8.24 31.8.23
£    £   
Trade creditors 60 60
Taxation and social security 26,161 22,671
Other creditors 21,907 7,025
48,128 29,756

6. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 31.8.24 31.8.23
value: £    £   
1 Ordinary 'A' £1 1 1

Qualipharm Consultancy Ltd (Registered number: SC483772)

Notes to the Financial Statements - continued
for the Year Ended 31 August 2024

7. DIRECTOR'S ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to a director subsisted during the years ended 31 August 2024 and 31 August 2023:

31.8.24 31.8.23
£    £   
Ms C Tsang
Balance outstanding at start of year - 148,739
Amounts repaid - (148,739 )
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year - -